Related Experiment Videos
Combined use of labetalol and nifedipine in controlling the cardiovascular response from ECT
G S Figiel1, B DeLeo, C F Zorumski
1Department of Psychiatry, Washington University School of Medicine, St Louis MO.
Insights
Combining nifedipine with labetalol safely controlled blood pressure during electroconvulsive therapy (ECT) in elderly patients. This combination effectively managed hypertension without adverse effects or impacting seizure duration.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Elderly patients undergoing electroconvulsive therapy (ECT) face risks of serious cardiac complications.
- Cardiac medications are frequently used to mitigate cardiovascular responses during ECT.
- Labetalol effectively controls heart rate but may not sufficiently manage blood pressure in some patients.
Purpose of the Study:
- To evaluate the safety and efficacy of combining nifedipine with labetalol for blood pressure control during ECT.
- To assess the management of elderly patients with inadequately controlled blood pressure on labetalol alone.
Main Methods:
- A study involving ten elderly patients receiving ECT.
- Patients received a combination of nifedipine and labetalol for blood pressure management.
- Monitoring for adverse effects and seizure duration.
Main Results:
- The combination therapy was found to be safe and effective in controlling blood pressure.
- No adverse effects were observed in the study participants.
- Nifedipine did not appear to shorten the duration of seizures induced by ECT.
Conclusions:
- Combining nifedipine with labetalol is a safe and effective strategy for managing blood pressure during ECT in elderly patients.
- This combination offers a viable solution for patients whose blood pressure remains elevated despite labetalol treatment.
- Further research may explore broader applications of this combined therapy in similar patient populations.
Abstract:
Serious cardiac complications have been reported to occur in elderly depressed patients during a course of electroconvulsive therapy (ECT). As a result, cardiac medications are being used more often to dampen the cardiovascular response that occurs during an ECT treatment. Specifically, labetalol (a mixed alpha- and beta-blocker) has been shown to effectively control the heart rate during ECT. However, on occasion, patients may still exhibit sustained elevations of blood pressure during ECT when receiving labetalol. The optimum clinical management of these patients is unclear. The authors report on the safety and efficacy of combining nifedipine with labetalol to control blood pressure during ECT in ten elderly patients whose blood pressures were not adequately controlled by labetalol alone. No adverse effects were noted, nor did nifedipine appear to shorten seizure duration.